NCT02058004

Brief Summary

In modern anesthesia practice, the application of cricoid pressure during intubation is not infrequently used with the goal of preventing gastric-to-pulmonary aspiration. The evidence to support this practice is very scarce, and there have recently been many reports in the literature questioning the safety of cricoid pressure during intubation. Therefore, the goal of this study will be to randomize those at risk for microaspiration to receive cricoid pressure versus no cricoid pressure during intubation. We will specifically exclude those patients thought to be at the highest risk of aspiration (it is considered standard of care to perform cricoid pressure during intubation of this population). We will include those patients with some risk factors for aspiration (it is not considered standard of care to apply cricoid pressure during intubation of this population).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2014

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 7, 2014

Completed
6 months until next milestone

Study Start

First participant enrolled

August 1, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
Last Updated

January 1, 2016

Status Verified

December 1, 2015

Enrollment Period

2 months

First QC Date

January 26, 2014

Last Update Submit

December 30, 2015

Conditions

Keywords

MicroaspirationARDSHospital acquired pneumoniaCricoid pressure

Outcome Measures

Primary Outcomes (1)

  • Rate of microaspiration

    Tracheal secretions will be collected and later analyzed for the presence of pepsin A.

    Within 15 minutes of intubation

Secondary Outcomes (1)

  • Rate of ARDS

    Within 7 days of intubation

Other Outcomes (1)

  • Rate of hospital acquired pneumonia

    Within 7 days of intubation

Study Arms (2)

Cricoid pressure

EXPERIMENTAL

Patients randomized to receive cricoid pressure during endotracheal intubation.

Procedure: Cricoid pressure

No cricoid pressure

NO INTERVENTION

Patients randomized to receive no cricoid pressure during endotracheal intubation.

Interventions

Firm pressure on the cricoid cartilage with the goal of occluding the esophagus during endotracheal intubation.

Cricoid pressure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Obesity (BMI\>30)
  • Diabetes mellitus
  • Gastroesophageal reflux disease (GERD)
  • schedule cardiac, aortic vascular or non-cardiac thoracic procedure

You may not qualify if:

  • emergent surgery
  • risk factors for macroaspiration (non-fasting status, bowel obstruction, achalasia, hiatal hernia, esophageal stricture, esophageal diverticulum), altered level of consciousness, known pregnancy
  • preoperative ARDS
  • preoperative pneumonia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mayo Clinic - Saint Mary's Campus

Rochester, Minnesota, 55905, United States

Location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Respiratory Distress SyndromeHealthcare-Associated Pneumonia

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration DisordersCross InfectionInfectionsPneumoniaRespiratory Tract InfectionsIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • John Bohman, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor of Anesthesiology

Study Record Dates

First Submitted

January 26, 2014

First Posted

February 7, 2014

Study Start

August 1, 2014

Primary Completion

October 1, 2014

Study Completion

October 1, 2014

Last Updated

January 1, 2016

Record last verified: 2015-12

Locations